yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q26796415-E1016143-250C-4561-AF8C-4E78F5284A14
Q26796415-E1016143-250C-4561-AF8C-4E78F5284A14
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26796415-E1016143-250C-4561-AF8C-4E78F5284A14
Pharmacologic therapy for inflammatory bowel disease refractory to steroids
P2860
Q26796415-E1016143-250C-4561-AF8C-4E78F5284A14
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26796415-E1016143-250C-4561-AF8C-4E78F5284A14
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
237c01f3e1c377d1c2f2825011bd346701a5ba4a
P2860
Natalizumab Induction and Maintenance Therapy for Crohn's Disease